PF-06260414
≥98% (HPLC)
- Product Code: 71263
CAS:
1612755-71-1
| Molecular Weight: | 302.35 g./mol | Molecular Formula: | C₁₄H₁₄N₄O₂S |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD30480910 | |
| Melting Point: | Boiling Point: | 539.7±53.0°C(Predicted) | |
| Density: | 1.45±0.1 g/cm3(Predicted) | Storage Condition: | room temperature |
Product Description:
PF-06260414 is primarily used in the field of medical research, particularly in the study and development of treatments for various types of cancers. It functions as a kinase inhibitor, targeting specific enzymes that play a crucial role in cell signaling pathways. By inhibiting these enzymes, it helps in controlling the proliferation of cancer cells, thereby aiding in the development of targeted cancer therapies. Additionally, it is utilized in preclinical studies to understand the molecular mechanisms underlying tumor growth and to evaluate the efficacy of potential anticancer drugs. Its application extends to the exploration of combination therapies, where it is tested alongside other compounds to enhance therapeutic outcomes and reduce drug resistance in cancer treatment.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | Ft52,943.97 |
+
-
|
PF-06260414
PF-06260414 is primarily used in the field of medical research, particularly in the study and development of treatments for various types of cancers. It functions as a kinase inhibitor, targeting specific enzymes that play a crucial role in cell signaling pathways. By inhibiting these enzymes, it helps in controlling the proliferation of cancer cells, thereby aiding in the development of targeted cancer therapies. Additionally, it is utilized in preclinical studies to understand the molecular mechanisms underlying tumor growth and to evaluate the efficacy of potential anticancer drugs. Its application extends to the exploration of combination therapies, where it is tested alongside other compounds to enhance therapeutic outcomes and reduce drug resistance in cancer treatment.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
Ft0.00
Ft0.00
Total :